🇺🇸 FDA
Patent

US 10219492

Compounds and methods for altering RSV replication rate

granted A61KA61K31/713A61K45/06

Quick answer

US patent 10219492 (Compounds and methods for altering RSV replication rate) held by The Board of Regents of the University of Texas System expires Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Mar 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/713, A61K45/06